DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000MG4D0B7

Real-time Bid/Ask 07:00:04 2024-07-03 am EDT
0.76 EUR / 0.79 EUR -1.90% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-03 0.77 -2.53%
24-07-02 0.79 +2.60%
24-07-01 0.77 -2.53%
24-06-28 0.79 +1.28%
24-06-27 0.78 -2.50%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 05:28 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D0B
ISINDE000MG4D0B7
Date issued 2024-05-16
Strike 77.5 $
Maturity 2024-09-20 (80 Days)
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.81
Lowest since issue 0.21
Spread 0.03
Spread %3.80%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.24 USD
Average target price
83.43 USD
Spread / Average Target
+45.76%
Consensus